<i>E. coli</i>-Produced BMP-2 as a Chemopreventive Strategy for Colon Cancer: A Proof-of-Concept Study

<table>Schematic layout of the pTrcHis TOPO TA expression vector (Invitrogen, Netherland) used in this study for prokaryotic expression and the strategy employed to insert the ileal-derived human BMP-2 in this vector. The same vector, but driving LacZ expression, was used as control organism.</table>

Gastroenterology Research and Practice

fig2

Figure 2

Figure 2: <i>E. coli</i>-Produced BMP-2 as a Chemopreventive Strategy for Colon Cancer: A Proof-of-Concept Study 

Gastroenterology Research and Practice

E. coli-Produced BMP-2 as a Chemopreventive Strategy for Colon Cancer: A Proof-of-Concept Study

Figure 2